AstraZeneca
AZN
AZN
454 hedge funds and large institutions have $12.7B invested in AstraZeneca in 2017 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 171 increasing their positions, 123 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
2% less funds holding
Funds holding: 465 → 454 (-11)
11% less first-time investments, than exits
New positions opened: 48 | Existing positions closed: 54
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
454
Holding in Top 10
6
Calls
$165M
Puts
$138M
Top Buyers
| 1 | +$188M | |
| 2 | +$149M | |
| 3 | +$136M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$107M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$88.3M |
Top Sellers
| 1 | -$224M | |
| 2 | -$177M | |
| 3 | -$67.6M | |
| 4 |
Goldman Sachs
New York
|
-$40.4M |
| 5 |
Barclays
London,
United Kingdom
|
-$30M |